Annexon (NASDAQ:ANNX) President and CEO Doug Love outlined the company's late-stage pipeline and regulatory plans during a ...
Severe posttransfusion hyperhemolysis in a sickle cell patient produced profound anemia and lactic acidosis; terminal complement blockade with eculizumab stabilized hemolysis and enabled recovery.
Omeros Corporation today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros management will host a conference call and ...
Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDTCompany ParticipantsDouglas Love - CEO, President ...
Osteoarthritis is a degenerative joint disease, in which tissues in the joint break down over time. The condition can affect ...
RESEDA, CA - May 13, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource examining the ...
An estimated 595 million people globally are living with osteoarthritis. This makes it one of the leading causes of pain and ...
Discusses BGE-102 Clinical Results and Development Strategy for Cardiovascular and Retinal Disease May 8, 2026 12:30 PM ...
Company Expands Ownership-Driven Investment Model While Maintaining Insurance and InsurTech Operating FoundationCompany to Host Conference Call ...
Memopezil is designed to support several important aspects of cognitive wellness through its nootropic and ...
Across rural and urban communities alike, a quieter crisis has been unfolding for years hidden hunger. Families may eat ...
Company Expands Ownership-Driven Investment Model While Maintaining Insurance and InsurTech Operating Foundation Company to Host Conference Call Today at 4:30 PM Eastern Time LAKEWOOD, N.J., May 07, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results